Peripheral opioid receptor blockade increases postoperative morphine demands—A randomized, double-blind, placebo-controlled trial
Authors:
- 1 October 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 155 (10) , 2056-2062
Abstract
Pioid receptors. This trial examined the contribution of such receptors to clinical analgesia induced by intravenous morphine. We hypothesized that the selective blockade of peripheral opioid receptors by methylnaltrexone (MNX) would increase the patients’ demand for morphine to achieve satisfactory postoperative pain relief. In a double-blind, placebo-controlled, sequential 2-center trial, 50 patients undergoing knee replacement surgery were randomized (1:1) to receive either subcutaneous MNX (0.9 mg/kg) (hospital I: n = 14; hospital II: n = 11) or saline (hospital I: n = 13; hospital II: n = 12) at the end of surgery. The primary endpoint was the cumulative amount of intravenous morphine administered during the first 8 hours. Secondary endpoints were pain scores at rest and during movement (by numerical rating scale and McGill Questionnaire), vital signs, adverse side effects, and withdrawal symptoms. After MNX, demands for morphine were strongly (by about 40%) increased (hospital I: 35.31 ± 12.99 mg vs 25.51 ± 7.92 mg, P = 0.03; hospital II: 35.42 ± 11.73 mg vs 24.80 ± 7.84 mg, P = 0.02; pooled data: P < .001; means ± SD). Secondary endpoints were similar in all groups (P > .05). Thus, a significant proportion of analgesia produced by systemically administered morphine is mediated by peripheral opioid receptors. Drugs that selectively activate such receptors should have the potential to produce powerful clinical pain relief....Keywords
Funding Information
- International Anesthesia Research Society, Helmholtz Gemeinschaft
- European Commission (FP7-602891-2)
This publication has 45 references indexed in Scilit:
- Mu Opioid Receptors on Primary Afferent Nav1.8 Neurons Contribute to Opiate-Induced Analgesia: Insight from Conditional Knockout MicePLOS ONE, 2013
- Novel opioid antagonists for opioid-induced bowel dysfunctionExpert Opinion on Investigational Drugs, 2011
- Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesiaPain, 2011
- Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysisBMJ, 2011
- β-Endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Peripheral versus Central Antinociceptive Actions of 6-Amino Acid-Substituted Derivatives of 14-O-Methyloxymorphone in Acute and Inflammatory Pain in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2005
- No pain, no gain: clinical excellence and scientific rigour – lessons learned from IA morphinePain, 2002
- Peripheral morphine analgesia in dental surgeryPain, 1998
- No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.Journal of Clinical Investigation, 1996
- Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivityLife Sciences, 1982